BioSpace News Archive

Micro Blood Science Inc. today announces its plan to develop the next-generation blood test data management system which will securely store the blood test data derived from its proprietary finger prick blood test system, Lifee, thereby allowing the data to be used in a wide variety of medical and healthcare-related services.

Varian will pay A$28 per share in cash for the Australian medtech.

Under this agreement, BioDuro will promote and market Porton’s extensive and proven capabilities for pilot and large-scale GMP production of custom APIs and drug intermediates.

Varian today announced that it will webcast a conference call to discuss the details of the agreement, also announced today, to acquire all the outstanding shares of Sirtex Medical.

Mazor Robotics announced today that it will report financial results for the fourth quarter and full year ended December 31, 2017, before the U.S. markets open on Wednesday, February 14, 2018.

Aigenpulse today announced the appointment of Mr Nicholas Cross as Non-Executive Director. He joins the company at an exciting stage in its development to help guide the scale-up of the business.

Scientists discovered how a gene mutation affects T cell function to promote immune disorders and then tested a treatment based on the discovery.

CDI and Oppenheim have teamed up to drive awareness around irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO), two of the leading causes of digestive distress affecting tens of millions of people in the United States and around the world.

The Company is expanding its direct sales and support activity in North America, having recently opened a sales and support operation in New Jersey, and has established a network of distributors in Europe and the Far East to support the launch of its integrated Cyto-Mine Single Cell Analysis System.

During the quarter, revenues for the HOYA Group increased 11.6% year on year, reaching 136,759 million yen.